Table 8.
A general overview of learning-based methods that have been applied to the task of designing functional peptides.
| Task | Input data | Model | Output |
|---|---|---|---|
| Binders for Bcl-xL, Mcl-1, or Bfl-1 | Set of 10,000 previously generated binders | SORTCERY [171]: Support vector machine for prediction, applied to a larger sequence library | 36 high affinity binders for each target with Ki as low as 5.71.2 nM for Mcl-1, 1.320.18 nM for Bcl-xL, and 6.61.0 nM for Bfl-1 |
| Finding peptide hits for Sfp and AcpS | Experimental data of known hits and fragments that don’t bind, each round new data was added | POOL [172]: Naive Bayesian | Selective binders for Sfp or AcpS after 4 rounds |
| Design of cell permeable peptides | 600 PMO-miniprotein conjugates | RNN for generation and CNN for prediction [173] | Synthesized and characterized 12. Highly active for macromolecule delivery |
| Peptides with anticancer properties | Curated peptides from CancerPPD that target breast or lung cancer, pepCAST descriptors were used to find features | CPANN [174]: counter propagation artificial neural network for prediction and modLAMP for generation | 6/15 peptides predicted to have anticancer activity indeed showed anticancer activity |
| Design of chitin binding peptides | 21 million amino acid sequences taken from the Pfam database and 20000 sequences from the SCOPe database | Two Bi-LSTM each with 1024 hidden layers [175] | Interactive residues in the two predicted peptides matched experimentally known ones |
| Designing nonhemolytic AMPs | DBAASP database | RNN for classifying active, inactive, hemolytic, and nonhemolytic sequences [176] | 12/28 were active |